The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
Advancements in molecular biology technology allowed the development of promising biomarkers, such as Peripheral blood gene expression profiling (GEP) and cell-free DNA (cfDNA), for minimally invasive diagnosis and characterisation of allograft rejection.
The use of circulating GEP and cfDNA may offer advantages over invasive tissue biopsy as a quantitative measure for detection of transplant rejection, immunosuppression optimisation and follow-up after treatment. However, there is no standard recognition of the usage of this new technology.
With the intention of fostering awareness around this topic, during the TLJ 3.0 Consensus conference held in Prague, November 2022, a panel of experts developed guidelines on the use of Molecular Biology testing for Non-Invasive Diagnosis of Allograft Rejection pertaining to the Kidney, Heart & Lung, and Liver. These guidelines were submitted in the form of three papers and have been published on Transplant International.
This masterclass was designed based on the outcomes of these guidelines. It will cover all the cutting-edge technologies that are about to revolutionise the transplantation field, including cell-free DNA, new plasma, urinary and immune function biomarkers, gene-expression profiling, as well as recent advances on HLA and non-HLA antibodies.
Learning Objectives:
After attending this masterclass participants will be able to:
Solid Organ Transplant professionals who are within 5 years of senior appointment.
Professional Background: Nephrology, Cardio Thoracic, Scientist, Allied Health Care Professionals
Download the programme at this link
Session 1 Introduction of ESOT Guidelines on Biomarkers (14:30 – 16:00)
Moderator: Luciano Potena (Italy)
14:00 Welcome address
Speaker: David Cucchiari (Spain)
14:35 Overview of Biomarkers in Transplantation: What to expect?
Speaker: Carmen Lefaucheur (France)
15:00 Guidelines Presentation: Kidney ‘European Society of Organ Transplantation Consensus Statement on Testing for Non-Invasive Diagnosis of Kidney Allograft Rejection’
Speaker: Sook Hyeon Park (US)
15:20 Guidelines Presentation: Heart & Lung ‘European Society for Organ Transplantation Statement on the use of non-invasive biomarkers for cardiothoracic transplant rejection surveillance’
Speaker: Andriana Nikolova (US)
16:00 – 16:30 Coffee break
Session 2 Donor derived cfDNA (16:30 – 18:00)
Moderator: Carmen Lefaucheur (France)
16:30 Challenges of setting up of cfDNA assay
Speaker: Bianca de Nicolo (Italy)
16:55 cfDNA in Kidneys & Pancreas
Speaker: Louise Benning (Germany)
17:20 cfDNA in Heart & Lung
Speaker: Luciano Potena (Italy)
17:45 Panel Discussion
Session 3 Other Biomarkers (09:00 – 10:40)
Moderator: Eric Epailly (France)
09:00 Urinary
Speaker: David Cucchiari (Spain)
09:20 Gene expression
Speaker: Valentin Goutaudier (France)
09:40 Cardiac biomarkers
Speaker: Marta Jimenez Blanco Bravo (Spain)
10:00 Immune function biomarkers
Speaker: Delphine Kervella (Spain)
10:20 HLA and non-HLA donor specific antibodies
Speaker: Guido Moll (Germany)
10:40 – 11:00 Coffee break
Session 4 Clinical Case Discussion (11:00 – 12:00)
Format: Participants will be divided into two groups. Clinical case studies will be presented and discussed during the session
11:00 Clinical case discussion: Management of subclinical and of relapsing rejection in KTX: how biomarkers could be helpful
Moderators: Louise Benning (Germany), David Cucchiari (Spain)
11:25 Clinical case discussion: Management of rejection treatment in infected patients: how biomarkers can be helpful
Moderators: Marta Jimenez Blanco-Bravo (Spain), Luciano Potena (Italy)
11:50 Closing remarks
Speaker: Luciano Potena (Italy)
Organising Committee
David Cucchiari (Spain), Dilan Dabare (United Kingdom), Luciano Potena (Italy)
Confirmed Speakers
Mercure Hotel Stare Miasto
Pawia 18/B, 31-154 Kraków, Poland
The official language of the masterclass is English.
This masterclass is open to 25 participants and it is by application only. Registration is provided upon application approval.
Grant application
Successful candidates will receive a 300 EUR grant covering travel expenses. Accommodation will be provided by the Organisers at the venue of the Masterclass. For more information on how to apply, please click here.
Extended Deadline: 10 May 2024 – 23:59 CEST
Cancellation Policy
Cancellations must be written to Supriya Barve supriya.barve@esot.org
|
|
|
|
Giovanna Rossi – Senior Project Manager
Supriya Barve – Project Coordinator
This masterclass is possible thanks to the kind support of
This masterclass is open to 25 participants and it is by application only. Registration is provided upon application approval. Successful candidates will receive a 300 EUR grant covering travel expenses. Accommodation will be provided by the Organisers.
Read the Terms of Reference
Application materials
NEW Extended Deadline: 10 May 2024 – 23:59 CEST
Subject: Grant application for ESOT Masterclass 2024 _ Name of the applicant
